B
27.77
0.63 (2.32%)
| 前收盘价格 | 27.14 |
| 收盘价格 | 27.33 |
| 成交量 | 271,999 |
| 平均成交量 (3个月) | 318,805 |
| 市值 | 1,288,172,544 |
| 预期市盈率 (P/E Forward) | 250.00 |
| 价格/销量 (P/S) | 12.79 |
| 股市价格/股市净资产 (P/B) | 3.07 |
| 52周波幅 | |
| 利润日期 | 26 Feb 2025 - 3 Mar 2025 |
| 营业毛利率 | -24.54% |
| 营业利益率 (TTM) | -40.48% |
| 稀释每股收益 (EPS TTM) | -0.250 |
| 季度收入增长率 (YOY) | 29.70% |
| 总债务/股东权益 (D/E MRQ) | 8.65% |
| 流动比率 (MRQ) | 4.55 |
| 营业现金流 (OCF TTM) | 8.43 M |
| 杠杆自由现金流 (LFCF TTM) | 43.83 M |
| 资产报酬率 (ROA TTM) | -1.10% |
| 股东权益报酬率 (ROE TTM) | -3.32% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 混合的 | 混合的 | |
| 股票 | BioLife Solutions, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
-0.1
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -3.5 |
| 平均 | -0.13 |
|
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Core |
| 内部持股比例 | 2.47% |
| 机构持股比例 | 101.86% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 31.00 (Northland Capital Markets, 11.63%) | 购买 |
| 中 | 30.50 (9.83%) | |
| 低 | 30.00 (HC Wainwright & Co., 8.03%) | 购买 |
| 平均值 | 30.50 (9.83%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 27.25 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 06 Mar 2025 | 30.00 (8.03%) | 购买 | 26.80 |
| Northland Capital Markets | 08 Jan 2025 | 31.00 (11.63%) | 购买 | 27.69 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合